PointState Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-30,020
| Closed | -$18.2M | – | 136 |
|
|
2021
Q3 | $18.2M | Buy |
30,020
+7,020
| +31% | +$4.25M | 0.3% | 43 |
|
|
2021
Q2 | $12.8M | Buy |
+23,000
| New | +$12.8M | 0.22% | 53 |
|
|
2021
Q1 | – | Sell |
-35,733
| Closed | -$17.3M | – | 134 |
|
|
2020
Q4 | $17.3M | Buy |
35,733
+19,313
| +118% | +$9.33M | 0.32% | 52 |
|
|
2020
Q3 | $9.19M | Sell |
16,420
-25,927
| -61% | -$14.5M | 0.24% | 50 |
|
|
2020
Q2 | $26.4M | Buy |
42,347
+32,804
| +344% | +$20.5M | 0.8% | 26 |
|
|
2020
Q1 | $4.66M | Sell |
9,543
-125,025
| -93% | -$61.1M | 0.23% | 33 |
|
|
2019
Q4 | $50.5M | Buy |
134,568
+120,368
| +848% | +$45.2M | 0.92% | 28 |
|
|
2019
Q3 | $3.94M | Buy |
+14,200
| New | +$3.94M | 0.11% | 58 |
|
|
2017
Q3 | – | Sell |
-159,220
| Closed | -$78.2M | – | 151 |
|
|
2017
Q2 | $78.2M | Buy |
+159,220
| New | +$78.2M | 0.85% | 35 |
|